Form 8-K - Current report:
SEC Accession No. 0001437749-18-000707
Filing Date
2018-01-17
Accepted
2018-01-17 08:33:11
Documents
1
Period of Report
2018-01-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K avir20180116_8k.htm 8-K 35708
  Complete submission text file 0001437749-18-000707.txt   37072
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 18529812
SIC: 2836 Biological Products, (No Diagnostic Substances)